Alnylam Pharmace. buy SpringheelJack
Start price
08.05.20
/
50%
€130.98
Target price
08.07.20
-
Performance (%)
7.97%
End price
08.07.20
€141.42
Summary
This prediction ended on 08.07.20 with a price of €141.42. The BUY prediction by SpringheelJack finished with a performance of 7.97%. SpringheelJack has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -1.169% | -1.169% | 45.419% | 50.100% |
| iShares Core DAX® | 0.224% | 2.457% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 0.371% | -0.320% | 5.422% | 113.046% |
| iShares Nikkei 225® | 0.972% | -0.829% | 15.333% | 47.267% |
| iShares S&P 500 | 0.417% | -0.157% | 3.125% | 68.687% |
Comments by SpringheelJack for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.